Mochida Pharmaceutical

Update in progress

4534.T (Tokyo)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic

Mochida Pharmaceutical Co., Ltd. is a Tokyo-based Japanese company that develops, manufactures, and sells medicines and healthcare products. Its portfolio covers cardiovascular, obstetrics/gynecology, dermatology, psychiatry, and gastroenterology, including ulcerative colitis therapies such as Lialda and Cortiment, constipation treatments like Movicol, and other agents for gout, pulmonary hypertension, and dysmenorrhea. It also develops medical devices and skincare products; founded in 1913.

Company score

Sentiment: 0.34; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.44; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.12; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.16; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.25; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive